Sihuan Pharmaceutical Holdings GP Ltd is a pharmaceutical group focused on the research, development, production, and marketing of cardiovascular drugs, new medicines, and medical aesthetics products. The company operates through subsidiaries including Beijing Sihuan Pharmaceutical and Jilin Sihuan Pharmaceutical, and maintains a dedicated research institute for new drug development. Its product portfolio includes active pharmaceutical ingredients, large and small volume injections, freeze-dried powders, tablets, capsules, and granules. The company serves the Chinese market, distributing products to hospitals and end-users through a network of distributors. It engages in global project collaborations for its drug pipeline and has established partnerships for the commercialization of insulin products. The group was founded in 2001 and has undergone capital restructuring, including a private placement and relisting on the main board of the Stock Exchange of Hong Kong in 2010.

Summarised from the company's own disclosures, fiscal year ended Apr 2026

Industry Drug Manufacturers - General Homepage sihuanpharm.com
Sector Healthcare IR page sihuanpharm.com/zh-CN/investor
Tags
cardiovascular drugs, new medicines, medical aesthetics, insulin, active pharmaceutical ingredients, injections, tablets, capsules, granules, hospital distribution, Beijing Sihuan Pharmaceutical, Jilin Sihuan Pharmaceutical, Hainan Sihuan Pharmaceutical, Sihuan Drug Research Institute, Huisheng Biotech
Press page —

Metrics

Valuation  
Market cap HK$ 6.6B
Market cap (USD) $ 841.114M
P/E 32.81
PEG —
P/BV 0.81
P/S 2.13
P/OCF -274.26
P/FCF —
Dividend yield 1.5%
Turnover / mcap 0.26%
Returns  
ROE 3.0%
ROI 2.5%
ROIC 8.6%
Profit margin 6.9%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) No
Debt/Equity 4.6%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 17.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 2.618B 1.901B 1.861B 2.181B 3.291B 2.464B 2.887B 2.917B 2.746B 3.186B 3.167B 3.084B 4.733B 3.043B 2.242B 1.037B
Net profit 179.696M -216.662M -54.017M -1.915B 416.509M 473.382M -2.753B 1.62B 1.449B 1.708B 2.062B 1.671B 1.303B 904.402M 824.048M 522.065M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price — — — 0.93 — 0.85 1.53 1.24 — — — — — — — —
Price performance 12m — — — — — -0.45 0.19 — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Sihuan Pharmaceutical Holdings GP Ltd (ticker 460), listed in Hong Kong.

ETFs Holding Sihuan Pharmaceutical Holdings GP Ltd

ETF Weight in ETF Shares Market value As of
AVEE 0.03% 408,000 $ 40.103K Nov 16, 2026
AVSE 0.02% 419,000 $ 41.184K Nov 16, 2026
DFEV 0.01% 2,012,000 $ 203.902K Nov 12, 2026
DFEM 0.00% 3,271,000 $ 331.493K Nov 12, 2026
DFAE 0.00% 3,213,000 $ 325.615K Nov 12, 2026
DFAX 0.00% 2,693,000 $ 272.917K Nov 12, 2026
AVEM 0.00% 446,000 $ 43.838K Nov 16, 2026